Evommune, Inc. (EVMN)
24.11
+0.48
(+2.03%)
USD |
NYSE |
May 05, 16:00
24.11
0.00 (0.00%)
After-Hours: 20:00
Evommune Total Assets (Quarterly) : 224.95M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 40.87B |
| Nektar Therapeutics | 280.41M |
| Moderna, Inc. | 11.49B |
| Apogee Therapeutics, Inc. | 937.13M |
| Vertex Pharmaceuticals, Inc. | 26.48B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.38M |
| Shareholders Equity (Quarterly) | 205.57M |
| Debt to Equity Ratio | 0.01 |
| Current Ratio | 8.570 |
| Net Debt Paydown Yield | -0.08% |